Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting tyrosine kinases and other signaling proteins involved in tumor growth. Its structure allows for selective modification, enabling optimization of drug potency and selectivity. Commonly employed in research and development of small-molecule therapeutics in oncology and inflammatory diseases.